Dare Bioscience, Inc. Cash, Period Increase (Decrease)
Dare Bioscience, Inc. (DARE) reported Cash, Period Increase (Decrease) of -$5.21 thousand for the 6-month period ending 2017-06-30, per its 8-K/A filed 2017-10-02.
Discontinued › Notes
us-gaap:CashPeriodIncreaseDecrease · last filed 2017-10-02
| Period end | Cash, Period Increase (Decrease) 6 month | Cash, Period Increase (Decrease) 7 month | Cash, Period Increase (Decrease) 12 month |
|---|---|---|---|
| 2017-06-30 | -$5.21K 8-K/A · filed 2017-10-02 | ||
| 2016-12-31 | -$174.80K 8-K/A · filed 2017-10-02 | ||
| 2016-06-30 | -$182.51K 8-K/A · filed 2017-10-02 | ||
| 2015-12-31 | $219.41K 8-K/A · filed 2017-10-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |